PAREXEL INTERNATIONAL CORP (NASDAQ:PRXL), Up By 5.56% ($1.29) From $23.210 After BUYINS.NET Report Predicted Strength After Ear
March 8, 2011 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Friday, January 28th 2011 stating that PAREXEL INTERNATIONAL CORP (NASDAQ:PRXL) was expected to be Up After its earnings release. Click here to view the BUYINS.NET report: http://www.buyins.net/tools/symbol_stats.php?sym=prxl
At the time this story was written, PAREXEL INTERNATIONAL CORP (NASDAQ:PRXL) is Up By 5.56% ($1.29) From $23.210 since the BUYINS.NET report was released.
The movement of stock prices in the days and weeks leading to and following earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php
PAREXEL INTERNATIONAL CORP (NASDAQ:PRXL) - PAREXEL International Corporation, a biopharmaceutical services company, provides clinical research, medical communications services, consulting and informatics, and technology products and services to the pharmaceutical, biotechnology, and medical device industries worldwide. It operates in three segments: Clinical Research Services (CRS), PAREXEL Consulting and Medical Communications Services (PCMS), and Perceptive Informatics, Inc. (Perceptive). The CRS segment provides clinical trials management and biostatistics, data management, and clinical pharmacology, as well as related medical advisory, patient recruitment, and investigator site services. It manages various aspects of clinical trials, including study and protocol design, case report form design, site and investigator recruitment, patient enrollment, study monitoring and data collection, data analysis, report writing, and medical services. This segment provides services in various therapeutic areas, including cardiology, oncology, infectious diseases, neurology, allergy/immunology, endocrinology/metabolism, gastroenterology, obstetrics/gynecology, orthopedics, pediatrics, psychiatry, and transplantation. The PCMS segment offers technical advice in areas, such as drug development, regulatory affairs, and biopharmaceutical process and management consulting. It also provides market development, product development, and targeted communications services in support of product launch. In addition, its consultants identify alternatives and propose solutions to address clients product development, registration, and commercialization issues, as well as offers health policy consulting and reimbursement services. The Perceptive segment provides information technology solutions comprising medical imaging services, RTSM/integrated voice response products, CTMS, EDC, Web-based portals, systems integration, and patient diary applications. The company was founded in 1983 and is headquartered in Waltham, Massachusetts.
About BUYINS.NET
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.
INVESTMENTS & TRADING
SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.
GATS -- tracks and quantifies known trading strategies.
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. PAREXEL INTERNATIONAL CORP (NASDAQ:PRXL) has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.
Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net